Pharmaxis phase 2 trial scheduled to commence in second half of 2017

July 28 (Reuters) - Pharmaxis Ltd (PXS)

  • Phase 2 trial is scheduled to commence in second half of 2017, and this will trigger payment to Pharmaxis of about A$14 million


To read reuters' full disclaimer click here
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.